Evidence map›Paper›PMID 34293963›Full record

ArticleJournal of diabetes science and technology2022

Simulation Platform Development for Diabetes and Technology Self-Management.

Eileen R Faulds, Michael Rayo, Claudia Lewis, Carl W Noble, Ryan Gifford, Mary Beth Happ, Lilly Joyce, Kathleen Dungan

Open access · greenAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Eileen R FauldsThe Ohio State University College of Nursing, Columbus, OH, USA.ORCID 0000-0003-2315-1146
Michael RayoThe Ohio State University College of Engineering, Columbus, OH, USA.
Claudia LewisWake Forest School of Medicine, Winston-Salem, NC, USA.
Carl W NobleUniversity of Cincinnati Medical Center, Cincinnati, OH, USA.
Ryan GiffordThe Ohio State University College of Engineering, Columbus, OH, USA.
Mary Beth HappThe Ohio State University College of Nursing, Columbus, OH, USA.
Lilly JoyceThe Ohio State University College of Nursing, Columbus, OH, USA.
Kathleen DunganThe Ohio State University Medical Center, Columbus, OH, USA.
The Ohio State University · USThe Ohio State University Wexner Medical Center · USUniversity of Cincinnati · USWake Forest University · US

Funding

The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve HealthUL1TR002733 · NCATS · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2018 to 2022
$28.9M
NCATS NIH HHS UL1 TR002733
6 · The paper itself

Abstract

backgroundSpecialized education is critical for optimal insulin pump use but is not widely utilized or accessible. We aimed to (1) test the usability and acceptability of A1Control, a simulation platform supporting insulin pump education, and (2) determine predictors of performance.

methodRural adult insulin pump users with type 1 diabetes (T1D) participated in a mixed methods usability study in 2 separate rounds. Participants navigated 3 simulations (ie, infusion site occlusion, hypoglycemia, exercise). Net Promoter Score (NPS) and Systems Usability Scale (SUS) were administered. Semi-structured interviews and direct observation were used to assess perceived usability, acceptability and performance. Synthetic Minority Oversampling Technique was used to fit predictive models for visualization of patterns leading to good or poor A1Control performance.

resultsParticipants (

conclusionA1Control shows potential to increase access and frequency of self-management and technology education. Additional study is needed to determine sustained engagement and benefit.

Indexed as

Diabetes Mellitus, Type 1HypoglycemiaSelf-ManagementAdultAgedBlood GlucoseBlood Glucose Self-MonitoringHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsMiddle AgedTechnologyBlood GlucoseHypoglycemic AgentsInsulinautomated insulin delivery devicescontinuous glucose monitoringdiabetes self-management educationInsulin pumpsimulation

Identifiers

PMID34293963
PMCPMC9631530
OpenAlexW3184860356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.